GERN · Geron Corporation
AI read · Good for GERN
The AI's read
The sales gains and lower costs give Geron more room to fund its commercial work and research. Its cash balance adds flexibility. Management also expects full-year sales near the upper end of its $220 million to $240 million forecast. European plans are still being explored, and discussions continue about a trial review, but no timeline change was reported.